Skip to main content

ADVERTISEMENT

peripheral artery disease

Review
07/12/2023

Daniel J. Snyder, MD1; Robert S. Zilinyi, MD2; Sonal Pruthi, MD2; Sareena George, MD2; Ari J. Mintz, DO2; Sanjum S. Sethi, MD, MPH2; Sahil A. Parikh, MD2

1Department of Medicine, Columbia University Irving Medical Center, NewYork-Presbyterian, New York, New York; 2Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center, New York, New York

Daniel J. Snyder, MD1; Robert S. Zili...
The authors review the applications and supporting data for the use of intravascular ultrasound and optical coherence tomography in infrainguinal endovascular intervention.
The authors review the applications and supporting data for the use of intravascular ultrasound and optical coherence tomography in infrainguinal endovascular intervention.
The authors review the...
07/12/2023
Vascular Disease Management
Original Contribution
11/30/2022

Steven Meadors, MD1;  Andrea Klein, MD1;  Haekyung Jeon-Slaughter, PhD1,2; Omar Jawaid, MD3,4;  Ehrin J. Armstrong, MD3,4;  Rahul Banerjee5;  Mohamad Amer Alaiti, MD1,2;  Bala Ramanan, MBBS1,2;  J. Gregory Modrall, MD1,2;  Subhash Banerjee, MD1,2;  Shirling Tsai, MD1,2

Steven Meadors, MD1;  Andrea Klein, M...
Few studies have directly compared procedural details and outcomes after retrograde vs antegrade crossing of FP lesions.
Few studies have directly compared procedural details and outcomes after retrograde vs antegrade crossing of FP lesions.
Few studies have directly...
11/30/2022
Journal of Invasive Cardiology
Brief Contribution
12/01/2021

Yashasvi Chugh, MD1;  Jaikirshan J. Khatri, MD2;  Mehdi H. Shishehbor, DO, MPH, PhD3;  Subhash Banerjee, MD4;  Kevin Croce, MD5;  Khaldoon Alaswad, MD6;  Bilal Murad, MD1;  Santiago Garcia, MD1;  M. Nicholas Burke, MD1;  Emmanouil S. Brilakis, MD, PhD1

Yashasvi Chugh, MD1;  Jaikirshan J. K...
Currently only the peripheral intravascular lithotripsy device is approved for use in the United States. We queried the United States FDA MAUDE database from January 1, 2016 to December 14, 2020 for all reports of adverse events and modes of...
Currently only the peripheral intravascular lithotripsy device is approved for use in the United States. We queried the United States FDA MAUDE database from January 1, 2016 to December 14, 2020 for all reports of adverse events and modes of...
Currently only the peripheral...
12/01/2021
Journal of Invasive Cardiology
Adam L. Isaac, DPM
Blog
08/19/2021
Adam L. Isaac DPM FACFAS
According to a recent publication in Diabetologia, there is an increased risk of infection-related hospitalization in patients with diabetes.
According to a recent publication in Diabetologia, there is an increased risk of infection-related hospitalization in patients with diabetes.
According to a recent...
08/19/2021
Podiatry Today
Original Contribution
06/25/2021

J.A. Mustapha, MD1;  Fadi Saab, MD1;  Theresa N. McGoff, BSN2;  Sara Finton, BSN3;  George Adams, MD4;  J. Randall Mullins, MD5;  Michael R. Jaff, DO6;  Farhan Khawaja, MD7;  Philip P. Goodney, MD8;  Gabor Matos, MD9;  M. Laiq Raja, MD10;  Michael Sumners, DO2

J.A. Mustapha, MD1;  Fadi Saab, MD1; ...
Despite medical advancements, PAD and CLI continue to increase globally. Treatment for PAD/CLI varies widely and patients with CTOs may be more challenging to treat, requiring specialized crossing techniques and modalities. The objective of...
Despite medical advancements, PAD and CLI continue to increase globally. Treatment for PAD/CLI varies widely and patients with CTOs may be more challenging to treat, requiring specialized crossing techniques and modalities. The objective of...
Despite medical advancements,...
06/25/2021
CardioVascular
Review
06/08/2021

John N. Evans, DPM1;  Nicholas C. Claussen, BA2;  Courtney S. Leslie, PharmD2; Kenneth T. Moore, MA, MS2

John N. Evans, DPM1;  Nicholas C. Cla...
This review serves to introduce the most recent data with a factor Xa inhibitor as a novel antithrombotic strategy for PAD. 
This review serves to introduce the most recent data with a factor Xa inhibitor as a novel antithrombotic strategy for PAD. 
This review serves to introduce...
06/08/2021
The STAND Trial: How the MicroStent Attempts to Break Through Barriers in Below-the-Knee CLI
Clinical Update
05/21/2020

Omosalewa Adenikinju, MD; Michael Patel, MD; Adam Zybulewski, MD; Brandon Olivieri, MD; Robert E. Beasley, MD

Mount Sinai Medical Center, Miami Beach, Florida

Omosalewa Adenikinju, MD; Michael Pat...
To understand the intent behind the STAND (Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee) trial, one must comprehend the barriers of clinical success in BTK revascularization.
To understand the intent behind the STAND (Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee) trial, one must comprehend the barriers of clinical success in BTK revascularization.
To understand the intent behind...
05/21/2020
Vascular Disease Management
Treatment of Common Femoral Artery Lesions Involving the Superficial and Profunda Femoral Artery Bifurcation
Original Research
05/15/2020

Alberto Cereda, MD1; Paolo Cioffi, MD1; Riccardo Iorio, MD1; Attilio Cotroneo, MD2; Giuseppe Celano, MD1; Sante Bongo, MD1; Gaetano Chiricolo, MD3; Giuseppe Sangiorgi, MD3

1Department of Cardiology and 2Department of Vascular Surgery, Clinica San Gaudenzio, Novara, Italy; 3Department of Systemic Medicine, Institute of Cardiology, University of Tor Vergata, Rome, Italy

Alberto Cereda, MD1; Paolo Cioffi, MD...
The authors repot on 2 cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.
The authors repot on 2 cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.
The authors repot on 2 cases at...
05/15/2020
Vascular Disease Management
EP Tips & Techniques
07/23/2019

Jihad A. Mustapha, MD1;  Marianne Brodmann, MD2;  Patrick J. Geraghty, MD3;  Fadi Saab, MD1;  Richard A. Settlage, MS4;  Michael R. Jaff, DO5; on behalf of the Lutonix BTK Study Investigators

Jihad A. Mustapha, MD1;  Marianne Bro...
We hypothesized that a drug-coated balloon could improve treatment efficacy while maintaining safety when compared with percutaneous transluminal angioplasty for the treatment of atherosclerotic infrapopliteal arterial lesions.
We hypothesized that a drug-coated balloon could improve treatment efficacy while maintaining safety when compared with percutaneous transluminal angioplasty for the treatment of atherosclerotic infrapopliteal arterial lesions.
We hypothesized that a...
07/23/2019
Journal of Invasive Cardiology
Original Contribution
09/30/2018

Haekyung Jeon-Slaughter, PhD1,2;  Houman Khalili, MD1,2;  Shirling Tsai, MD1,2;  Ehrin J. Armstrong, MD3;  Nicolas W. Shammas, MD4;  Omar Jawaid, MD3;  Hua Lu, MD1,2;  Tayo Addo, MD1;  Osvaldo Gigliotti, MD5;  Mazen Abu-Fadel, MD6;  Subhash Banerjee, MD1,2

Haekyung Jeon-Slaughter, PhD1,2;  Hou...
This study compared clinically driven target-lesion revascularization, target-vessel revascularization, and target-limb revascularization outcomes at 1 year between drug-eluting stent and bare-metal stent treatments in a real-world setting.
This study compared clinically driven target-lesion revascularization, target-vessel revascularization, and target-limb revascularization outcomes at 1 year between drug-eluting stent and bare-metal stent treatments in a real-world setting.
This study compared clinically...
09/30/2018
Journal of Invasive Cardiology